Pathophysiology of insulin resistance in human disease

Physiological Reviews

Volumn 75, Issue 3, 1995, Pages 473-486

  Reaven, Gerald M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROINSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

CLINICAL FEATURE; DYSLIPIDEMIA; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SYNDROME X;

EID: 0029037649     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.1995.75.3.473     Document Type: Review

References (121)

1. ANDERSON, E. A., AND A. L. MARK. The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension Dallas 21: 136-141, 1993.
2. ASSMANN, G., AND H. SCHULTE. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am. J. Cardiol. 70: 733-737, 1992.
3. AUSTIN, M. A. Plasma triglyceride and coronary heart disease. Arteriosclerosis Thromb. 11: 2-14, 1991.
4. AUSTIN, M. A., J. L. BRESLOW, C. H. HENNEKENS, J. E. BURING, W. S. WILLETT, AND R. M. KRAUSS. Low-density lipoprotein sub-class patterns and risk of myocardial infarction. J. Am. Med. Assoc. 260: 1917-1921, 1988.
5. AUSTIN, M. A., M.-C. KING, K. M. VRANIZAN, AND R. M. KRAUSS. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 82: 495-506, 1990.
6. BEST, J., R. JUDZEWITSCH, M. PFEIFER, J. BEARD, J. KOLTER, AND D. PORTE, JR. The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin dependent diabetes. Diabetes 31: 333-338, 1982.
7. BHARGAVA, R., M. Y. ZHOU, J. L. JEPPESEN, P. SCHAAF, C. L. CUNHNGBEARD, Y.-D. I. CHEN, AND G. M. REAVEN. Accentuation of postprandial lipemia by low fat-high carbohydrate diets (Abstract). Clin. Res. 41: 53A, 1993.
8. BOGARDUS, C., S. LILLIOJA, B. V. HOWARD, G. M. REAVEN, AND D. MOTT. Relationships between insulin secretion, insulin action and fasting plasma glucose concentration in nondiabetic and non-insulin dependent diabetic subjects. J. Clin. Invest. 74: 1238-1246, 1984.
9. BOGARDUS, C., S. LILLIOJA, D. M. MOTT, C. HOLLENBECK, AND G. M. REAVEN. Relationship between degree of obesity and in vivo insulin action in man. Am. J. Physiol. 248 (Endocrinol. Metab. 11): E286-E291, 1985.
10. BONADONNA, R. C., L. C. GROOP, K. ZYCH, M. SHANK, AND R. A. DEFRONZO. Dose-dependent effect of insulin on plasma free fatty acid turnover oxidation in humans. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E736-E750, 1990.
11. BRANDS, M. W., D. A. HILDEBRANDT, H. L. MIZELLE, AND J. E. HALL. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R764-R768, 1991.
12. BRINTON, E. A., S. EISENBERG, AND J. L. BRESLOW. Human HDL cholesterol levels are determined by ApoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Arteriosclerosis Thromb. 14: 707-720, 1994.
13. CAMBIEN, F., A. JAQUESON, J. L. RICHARD, J. M. WARNET, P. DUCIMETIERE, AND J. R. CLAUDE. Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris prospective study. Am. J. Epidemiol. 124: 624-632, 1986.
14. CAMPBELL, P. J., L. J. MANDARINO, AND J. E. GERICH. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 37: 15-21, 1988.
15. CASTELLI, W. P., J. T. DOYLE, T. GORDON, C. G. HAMES, M. C. HJORTLAND, S. B. HULLEY, A. KAGAN, AND W. J. ZUKEL. HDL cholesterol and other lipids in coronary heart disease. Circulation 55: 767-772, 1977.
16. CHEN, Y.-D. I., A. GOLAY, A. L. M. SWISLOCKI, AND G. M. REAVEN. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 64: 17-21, 1987.
17. CHEN, Y.-D. I., C.-Y. JENG, C. B. HOLLENBECK, M.-S. WU, AND G. M. REAVEN. Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes. J. Clin. Invest. 82: 21-25, 1988.
18. CHEN, Y.-D. I., W. H.-H. SHEU, A. L. M. SWISLOCKI, AND G. M. REAVEN. High density lipoprotein turnover in patients with hypertension. Hypertension Dallas 17: 386-393, 1991.
19. CHEN, Y.-D. I., S. SWAMI, R. SKOWRONSKI, A. COULSTON, AND G. M. REAVEN. Differences in postprandial lipemia between patients with normal glucose tolerance and non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 72: 172-177, 1993.
20. CHEN, Y.-D. I., A. L. M. SWISLOCKI, C.-Y. JENG, J.-H. JUANG, AND G. M. REAVEN. Effect of time on measurement of hepatic glucose production. J. Clin. Endocrinol. Metab. 67: 1084-1088, 1988.
21. CHILES, R., AND M. TZAGOURNIS. Excessive serum insulin response to oral glucose in obesity and mild diabetes. Diabetes 19: 458-464, 1970.
22. COLLINS, R., R. PETO, S. MACMAHON, P. HEBERT, N. H. FIEBACH, K. A. EBERLEIN, J. GODWIN, N. QIZILBASH, J. O. TAYLOR, AND C. H. HENNEKENS. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reduction in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 335: 827-838, 1990.
23. CRIQUI, M. H., G. HEISS, R. COHN, L. D. COWAN, C. M. SUCHINDRAN, S. BANGDIWALA, S. KRITCHEVSKY, D. R. JACOBS, H. K. O'GRADY, AND C. E. DAVIS. Plasma triglyceride level and mortality from coronary heart disease. N. Engl. J. Med. 328: 1220-1225, 1993.
24. CROUSE, J. R., J. S. PARKS, AND H. M. SCHEY. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J. Lipid Res. 26: 566-575, 1985.
25. DEFRONZO, R. A., R. GUNNARSSON, O. BJORKMAN, M. OLSSON, AND J. WAHREN. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent diabetes mellitus. J. Clin. Invest. 76: 149-155, 1985.
26. DEFRONZO, R. A., D. SIMONSON, AND E. FERRANNINI. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin dependent) diabetes mellitus. Diabetologia 23: 313-319, 1982.
27. DUCIMETIERE, P., E. ESCHWEGE, L. PAPOZ, J. L. RICHARD, J. R. CLAUDE, AND G. ROSSELIN. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19: 205-210, 1980.
28. FACCHINI, F., Y.-D. I. CHEN, C. CLINKINGBEARD, J. JEPPESEN, AND G. M. REAVEN. Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am. J. Hypertens. 5: 694-699, 1992.
29. FACCHINI, F., Y.-D. I. CHEN, C. B. HOLLENBECK, AND G. M. REAVEN. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. J. Am. Med. Assoc. 266: 3008-3011, 1991.
30. FALKNER, B., S. HULMAN, AND H. KUSHNER. Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension Dallas 22: 18-25, 1993.
31. FALKNER, B., S. HULMAN, J. TENNENBAUM, AND H. KUSHNER. Insulin resistance and blood pressure in young black men. Hypertension Dallas 16: 706-711, 1990.
32. FERRARI, P., P. WEIDMANN, S. SHAW, D. GIACHINO, W. RIESEN, Y. ALLEMANN, AND G. HEYNEN. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am. J. Med 91: 589-596, 1991.
33. FIRTH, R. G., P. M. BELL, H. M. MARSH, I. HANSEN, AND R. A. RIZZ. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J. Clin. Invest. 77: 1525-1532, 1986.
34. FOLEY, J. E. Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care 15: 773-781, 1992.
35. FRAZE, E., C. C. DONNER, A. L. M. SWISLOCKI, Y.-A. M. CHIOU, Y.-D. I. CHEN, AND G. M. REAVEN. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J. Clin. Endocrinol. Metab. 61: 807-811, 1985.
36. FULLER, J. H. Causes of death in diabetes mellitus. Horm. Metab. Res. 15, Suppl: 3-9, 1985.
37. FULLER, J. H., M. J. SHIPLEY, G. ROSE, R. J. JARRETT, AND H. KEEN. Coronary-heart-disease risk and impaired glucose tolerance. Lancet i: 1373-1376, 1980.
38. GINSBERG, H., G. KIMMERLING, J. M. OLEFSKY, AND G. M. REAVEN. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J. Clin. Invest. 55: 454-461, 1975.
39. GINSBERG, H., J. M. OLEFSKY, AND G. M. REAVEN. Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes 23: 674-678, 1974.
40. GOLAY, A., A. L. M. SWISLOCKI, Y.-D. I. CHEN, AND G. M. REAVEN. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism 36: 692-696, 1897.
41. GOLAY, A., L. ZECH, M.-Z. SHI, Y.-A. M. CHIOU, G. M. REAVEN, AND Y.-D. I. CHEN. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J. Clin. Endocrinol. Metab. 65: 512-518, 1987.
42. GROOT, P. H. E., W. A. H. J. VAN STIPHOUT, X. H. KRAUSS, H. JENSEN, A. VAN TOL, E. VAN RAMSHORST, S. CHIN-ON, A. HOFMAN, S. A. CRESSWELL, AND L. HAVEKES. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary arterosclerosis. Arteriosclerosis Thromb. 11: 653-662, 1991.
43. HAFFNER, S. M., M. P. STERN, B. D. MITCHELL, H. P. HAZUDA, AND J. K. PATTERSON. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39: 283-288, 1990.
44. HALL, J. E., M. W. BRANDS, S. D. KIVLIGHN, H. L. MIZELLE, A. HILDEBRANDT, AND C. A. GAILLARD. Chronic hyperinsulinemia and blood pressure. Hypertension Dallas 15: 519-527, 1990.
45. HAMSTEN, A., B. WIMAN, U. DEFAIRE, AND M. BLOMBACK. Increased plasma level of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med. 313: 1557-1563, 1985.
46. HO, L. T., Z. Y. CHANG, J. T. WANG, S. H. LI, Y. F. LIU, Y.-D. I. CHEN, AND G. M. REAVEN. Insulin insensitivity in offspring of parents with type 2 diabetes mellitus. Diabetic Med. 7: 31-34, 1990.
47. HOLLENBECK, C. B., Y.-D. I. CHEN, AND G. M. REAVEN. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization. Diabetes 33: 622-626, 1984.
48. HOLLENBECK, C. B., AND G. M. REAVEN. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J. Clin. Endocrinol. Metab. 64: 1169-1173, 1987.
49. 3H-glucose infusion. Diabetologia 33: 603-610, 1990.
50. HOTHER-NIELSEN, O., AND H. BECK-NIELSEN. Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus. Acta Endocrinol. 124: 637-645, 1991.
51. HULLEY, S. B., R. H. ROSENMAN, R. D. BAWOL, AND R. J. BRAND. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N. Engl. J. Med. 302: 1383-1389, 1980.
52. JENG, C.-Y., W. H.-H. SHEU, M. M.-T. FUH, Y.-D. I. CHEN, AND G. M. REAVEN. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with non-insulin-dependent diabetes mellitus. Diabetes. 43: 1440-1444, 1994.
53. JUHAN-VAGUE, I., M. C. ALESSI, AND P. VAGUE. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 34: 457-462, 1991.
54. JUHAN-VAGUE, I., S. G. THOMPSON, AND J. JESPERSEN. Involvement of the hemostatic system in the insulin resistance syndrome. Arteriosclerosis Thromb. 13: 1865-1873, 1993.
55. KAPLAN, N. M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 149: 1514-1520, 1989.
56. KARPE, F., J. M. BARD, G. STEINER, L. A. CARLSON, J. C. FRUCHART, AND A. HAMSTEN. HDLS and alimentary lipemia: studies in men with previous myocardial infarction at young age. Arteriosclerosis Thromb. 13: 11-22, 1993.
57. KOLTERMAN, O. G., R. S. GRAY, J. GRIFFIN, P. BRUNSTEIN, AND J. INSEL. Receptor and postreceptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 68: 957-969, 1981.
58. KROTKIEWSKI, M., K. MANDROUKAS, L. SJOSTROM, L. SULLIVAN, H. WETTERQVIST, AND P. BJORNSTORP. Effects of long-term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism 28: 650-658, 1979.
59. LAAKSO, M., S. LEHTO, I. PENTTILÄ, AND K. PYÖRÄLÄ. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88: 1421-1430, 1993.
60. LANDIN, K., L. TENGVORY, AND U. SMITH. Elevated flbrinogen and plasminogen activator (PAI-I) in hypertension are related to metabolic risk factors for cardiovascular disease. J. Intern. Med. 227: 273-278, 1990.
61. LAWS, A., A. C. KING, W. L. HASKELL, AND G. M. HEAVEN. Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men. Arteriosclerosis Thromb. 11: 1636-1642, 1991.
62. LAWS, A., M. L. STEFANICK, AND G. M. REAVEN. Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 69: 343-347, 1989.
63. LEAHY, J. L., H. E. COOPER, D. A. DEAL, AND G. C. WEIR. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. J. Clin. Invest. 77: 908-915, 1986.
64. LEWIS, G. F., N. M. O'MEARA, P. A. SOLTYS, J. D. BLACKMAN, P. H. IVERIUS, A. F. DRUETZLER, G. S. GETZ, AND K. S. POLONSKY. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. J. Clin. Endocrinol. Metab. 71: 1041-1050, 1990.
65. LEWIS, G. F., N. M. O'MEARA, P. A. SOLTYS, J. D. BLACKMAN, P. H. IVERIUS, W. L. PUGH, G. S. GETZ, AND K. S. POLONSKY. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J. Clin. Endocrinol. Metab. 72: 934-944, 1991.
66. LILLIOJA, S., D. M. MOTT, M. SPRAUL, R. FERRARO, J. E. FOLEY, E. RAVUSSIN, W. C. KNOWLER, P. H. BENNETT, AND C. BOGARDUS. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 1988-1992, 1993.
67. MANNINEN, V., L. TENKANEN, P. KOSKINEN, J. K. HUTTUNEN, M. MÄNTTÄRI, O. P. HEINONEN, AND M. H. FRICK. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki heart study: implications for treatment. Circulation 85: 37-45, 1992.
68. McKEIGUE, P. M., M. G. MARMOT, Y. D. SYNDERCOMBE COURT, D. E. COTTIER, S. RAHMAN, AND R. A. RIEMERSMA. Diabetes, hyperinsulinemia, and coronary risk factors in Bangladeshis in East London. Br. Heart J. 60: 390-396, 1988.
69. MEHTA, J., P. MEHTA, D. LAWSON, AND T. SALDEEN. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J. Am. Coll. Cardiol. 9: 263-268, 1987.
70. MODAN, M., H. HALKIN, S. ALMOG, A. LUSKY, A. ESHKOL, M. SHEFI, A. SHITRIT, AND Z. ZUCHS. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. Hypertension Dallas 75: 809-817, 1985.
71. NANKERVIS, A., J. PROIETTO, P. AITKEN, M. HAREWOOD, AND F. ALFORD. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in type 2 (non-insulin-dependent) diabetes. Diabetologia 23: 320-325, 1982.
72. NESTEL, P. J. Relationship between plasma triglycerides and removal of chylomicrons. J. Clin. Invest. 43: 943-949, 1964.
73. OLEFSKY, J. M., J. W. FARQUHAR, AND G. M. REAVEN. Reappraisal of the role of insulin in hypertriglyceridemia. Am. J. Med. 57: 551-560, 1974.
74. OLEFSKY, J. M., G. M. REAVEN, AND J. W. FARQUHAR. Effects of weight reduction on obesity, studies of carbohydrate and lipid metabolism. J. Clin. Invest. 53: 64-76, 1974.
75. PARAMO, J. A., M. COLUCCI, D. COLLEN, AND F. VAN DER WERF. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br. Med. J. 291: 575-576, 1985.
76. PATSCH, J. R., G. MIESEN BÖCK, T. HOPFERWIESER, V. HÜHLBERGER, E. KNAPP, J. K. DUNN, A. M. GOTTO, JR., AND W. PATSCH. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arteriosclerosis Thromb. 12: 1336-1345, 1992.
77. POTTER VAN LOON, B. J., C. KLUFT, J. K. RADDER, M. A. BLANKENSTEIN, AND A. E. MEINDERS. The cardiovascular risk factor plasminogen activator inhibitor type I is related to insulin resistance. Metabolism 42: 945-949, 1993.
78. PYÖRÄLÄ, K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two populations studies in Finland. Diabetes Care 2: 131-141, 1979.
79. RANDEREE, H. A., M. A. K. OMAR, A. A. MOTALA, AND M. A. SEEDAT. Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. Diabetes Care 15: 1258-1263, 1992.
80. REAVEN, G. M. Insulin resistance in noninsulin-dependent diabetes mellitus. Does it exist and can it be measured? Am. J. Med. 74: 3-17, 1983.
81. REAVEN, G. M. Role of insulin resistance in human disease. Diabetes 37: 1495-1607, 1988.
82. REAVEN, G. M. Insulin resistance, hyperinsulinemia, hypertriglayceridemia, and hypertension: parallels between human disease and rodent models. Diabetes Care 14: 195-202, 1991.
83. REAVEN, G. M. Are triglycerides important as a risk factor for coronary disease? Heart Dis. Stroke 2: 44-48, 1993.
84. REAVEN, G. M., R. J. BRAND, Y.-D. I. CHEN, A. K. MATHUR, AND I. GOLDFINE. Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes 42: 1324-1332, 1993.
85. REAVEN, G. M., AND Y.-D. I. CHEN. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab. Rev. 4: 639-652, 1988.
86. REAVEN, G. M., Y.-D. I. CHEN, C. B. HOLLENBECK, W. H.-H. SHEU, D. OSTREGA, AND K. S. POLONSKY. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J. Clin. Endocrinol. Metab. 76: 44-48, 1993.
87. REAVEN, G. M., Y.-D. I. CHEN, J. JEPPESEN, P. MAHEUX, AND R. M. KRAUSS. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J. Clin. Invest. 92: 141-146, 1993.
88. REAVEN, G. M., C. B. HOLLENBECK, AND Y.-D. I. CHEN. Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32: 52-55, 1989.
89. REAVEN, G. M., AND A. LAWS. Coronary heart disease in the absence of hypercholesterolaemia. J. Int. Med. 228: 415-417, 1990.
90. REAVEN, G. M., R. L. LERNER, M. P. STERN, AND J. W. FARQUHAR. Role of insulin in endogenous hypertriglyceridemia. J. Clin. Invest. 46: 1756-1767, 1967.
91. REAVEN, G., AND R. MILLER. Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes 17: 560-569, 1968.
92. REAVEN, G. M., AND R. G. MILLER. An attempt to define the nature of chemical diabetes using a multidimensional analysis. Diabetologia 16: 17-24, 1979.
93. ROSENTHAL, M., W. L. HASKELL, R. SOLOMON, A. WIDSTROM, AND G. M. REAVEN. Demonstration of a relationship between level of physical training and insulin-stimulated glucose utilization in normal humans. Diabetes 32: 408-411, 1983.
94. SAAD, M. F., S. E. KAHN, R. G. NELSON, D. J. PETTITT, W. C. KNOWLER, M. W. SCHWARTZ, S. KOWALYK, P. H. BENNETT, AND D. PORTE, JR. Disproportionately elevated proinsulin in Pima indians with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 70: 1247-1253, 1990.
95. SAAD, M., S. LILLIOJA, B. L. MYOMBA, C. CASTILLO, R. FERRARO, M. DE GREGORIO, E. RAVUSSIN, W. C. KNOWLER, P. H. BENNETT, B. V. HOWARD, AND C. BOGARDUS. Racial differences in the relation between blood pressure and insulin resistance. N. Engl. J. Med. 324: 733-739, 1991.
96. SAAD, M. F., D. J. PETTIT, D. M. MOTT, W. C. KNOWLER, R. G. NELSON, AND P. H. BENNETT. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1: 1356-1359, 1989.
97. SAKO, Y., AND V. E. GRILL. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127: 1580-1589, 1990.
98. SAVAGE, P. J., S. E. DIPPE, P. H. BENNETT, P. GORDEN, J. ROTH, N. B. RUSHFORTH, AND M. MILLER. Hyperinsulinemia and hypoinsulinemia: insulin responses to oral carbohydrate over a wide spectrum of glucose tolerance. Diabetes 25: 362-368, 1975.
99. SCHWARTZ, R. S. The independent effects of dietary weight loss and aerobic training on high density lipoproteins and apolipoprotein A-I concentrations in obese men. Metabolism 36: 165-171, 1987.
100. SHAMISS, A., J. CARROLL, AND T. ROSENTHAL. Insulin resistance in secondary hypertension. Am. J. Hypertens. 5: 26-28, 1992.
101. SHEN, S.-W., G. M. REAVEN, AND J. W. FARQUHAR. Comparison of impedance to insulin mediated glucose uptake in normal and diabetic subjects. J. Clin. Invest. 49: 2151-2160, 1970.
102. SICREE, R. A., P. Z. ZIMMET, H. O. M. KING, AND J. S. COVENTRY. Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36: 179-186, 1987.
103. SIMONS, L. A., T. DWYER, J. SIMONS, L. BERNSTEIN, P. MOCK, N. S. POONIA, S. BALASUBRAMANIAM, D. BARON, J. BRANSON, J. MORGAN, AND P. ROY. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Artherosclerosis 65: 181-189, 1987.
104. SIMPSON, H. S., C. M. WILLIAMSON, T. OLIVECRONA, S. PRINGLE, S., J. MACLEAN, AND A. R. LORIMER. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 85: 193-202, 1990.
105. SKOWRONSKI, R., C. B. HOLLENBECK, B. B. VARASTEH, Y.-D. I. CHEN, AND G. M. REAVEN. Regulation of non-esterfied fatty acid and glycerol concentration by insulin in normal individuals and patients with Type 2 diabetes. Diabetic Med. 8: 330-333, 1991.
106. SWENSON, T. L. The role of the cholesteryl ester transfer protein in lipoprotein metabolism. Diabetes Metab. Rev. 7: 139-153, 1991.
107. SWISLOCKI, A. L. M., Y.-D. I. CHEN, A. GOLAY, M.-O. CHANG, AND G. M. REAVEN. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 30: 622-626, 1987.
108. TEDDE, R., L. A. SECHI, A. MARIGLIANO, A. PALO, AND L. SCANO. Antihypertensive effect of insulin reduction in diabetic-hypertensive patients. Am. J. Hypertens. 2: 163-170, 1989.
109. TEMPLE, R. C., C. A. CARRINGTON, S. D. LUZIO, D. R. OWENS, A. E. SCHNEIDER, W. J. SOBEY, AND C. N. HALES. Insulin deficiency in non-insulin-dependent diabetes. Lancet 1: 293-295, 1989.
110. TOBEY, T. A., M. GREENFIELD, F. KRAEMER, AND G. M. REAVEN. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165-171, 1981.
111. VACCARO, O., K. J. RUTH, AND J. STAMLER. Relationship of post-load plasma glucose to mortality with 19-yr follow-up. Diabetes Care 13: 1328-1334, 1992.
112. WARRAM, J. H., B. C. MARTIN, A. S. KROLEWSKI, J. S. SOELDNER, AND C. R. KAHN. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of the diabetic parents. Ann. Intern. Med. 113: 909-915, 1990.
113. WILSON, D. E., L-F. CHAN, K. N. BUCHI, AND S. C. HORTON. Post-challenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia. Metabolism 34: 551-558, 1985.
114. WYNGAARDEN, J. B., AND W. N. KELLEY. Gout. In: Metabolic Basic of Inherited Disease (5th ed.). New York: McGraw-Hill, 1983, p. 1043-1144.
115. YOSHIOKA, N., T. KUZUYA, A. MATSUDA, M. TANIGUCHI, AND Y. IWAMOTO. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31: 355-360, 1988.
116. ZAVARONI, I., L. BONINI, M. FANTUZZI, E. DALL'AGLIO, M. PASSERI, AND G. M. REAVEN. Hyperinsulinaemia, obesity, and syndrome X. J. Int. Med. 235: 51-56, 1994.
117. ZAVARONI, I., E. DALL'AGLIO, O. ALPI, F. BRUSCHI, E. BONORA, A. PEZZAROSSA, AND V. BUTTURINI. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55: 259-266, 1985.
118. ZAVARONI, I., S. MAZZA, E. DALL'AGLIO, P. GASPARINI, M. PASSERI, AND G. M. REAVEN. Prevalence of hyperinsulinaemia in patients with high blood pressure. J. Int. Med. 231: 235-240, 1992.
119. ZAVARONI, I., S. MAZZA, M. FANTUZZI, E. DALL'AGLIO, E. BONORA, R. DELSIGNORE, M. PASSERI, AND G. M. REAVEN. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J. Int. Med. 234: 24-30, 1993.
120. ZHOU, Y.-P., and V. E. GRILL. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93: 870-876, 1994.
121. ZIMMET, P., S. WHITEHOUSE, F. ALFORD, AND D. CHISHOLM. The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance. Diabetologia 15: 23-27, 1978.